Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The pivotal Phase 2 trial (NCT04881760), published in The New England Journal of Medicine (Jastreboff et al., 2023), enrolled 338 adults with BMI 30 or higher
Some US packages can take longer
These regulations threaten the livelihoods of chronic illness patients, compounding pharmacists, naturopathic doctors, and integrative doctors whose businesses are centered around offering holistic treatment options like these
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM
US$ 23.87
US$ 20.80
US$ 24.26
US$ 21.02
US$ 22.47
US$ 21.75
